Suchergebnisse - "Chuang, W-L"

PubPharm (214)

1

Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

enthalten in: Journal of hepatology | 2024

von Polaris Observatory Collaborators | Razavi-Shearer, D. | Child, H. | +98

2

Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatment

enthalten in: Journal of viral hepatitis | 2018

von Agarwal, K. | Ahn, S. | Elkhashab, M. | +11

3

Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma : real-world east and west experience

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Chen, V. | Yeh, M. | Le, A. | +21

4

Responses are durable for up to 5 years after completion of peginterferon alfa-2a treatment in hepatitis B e antigen-positive patients

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Chuang, W. | Jia, J. | Chan, H. | +13

CommentIn: Aliment Pharmacol Ther. 2018 Jun;47(11):1556-1557. - PMID 29878418

5

Anti‐viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus‐related hepatocellular carcinoma : real‐world east and west experience

enthalten in: Alimentary Pharmacology & Therapeutics | 2018

von Chen, V. | Yeh, M. | Le, A. | +21

6

Strategies to manage hepatitis C virus infection disease burden-Volume 4

enthalten in: Journal of viral hepatitis | 2017

von Chen, D. | Hamoudi, W. | Mustapha, B. | +98

7

The present and future disease burden of hepatitis C virus infections with today's treatment paradigm : Volume 4

enthalten in: Journal of viral hepatitis | 2017

von Chan, H. | Chen, C. | Omede, O. | +98

8

Historical epidemiology of hepatitis C virus in select countries-volume 4

enthalten in: Journal of viral hepatitis | 2017

von Maaroufi, A. | Vince, A. | Himatt, S. | +98

9

Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B

enthalten in: Alimentary pharmacology & therapeutics | 2016

von Marcellin, P. | Ahn, S. | Chuang, W. | +27

10

Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa‐2a combination therapy for chronic hepatitis B

enthalten in: Alimentary pharmacology & therapeutics | 2016

von Marcellin, P. | Ahn, S. | Chuang, W. | +27

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]